Obesity and Weight Challenges
- Profiles in Catholicism
- May 25, 2023
- 2 min read
Updated: Feb 16
Medical Journal Articles
Trends in Obesity-Related Measures Among US Children, Adolescents, and Adults by Samuel D. Emmerich, DVM; Cheryl D. Fryar, MSPH; Bryan Stierman, MD, MPH; et al JAMA. February 13, 2025.
Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists by Jamy D. Ard, MD, Kristina H. Lewis, MD , and Justin B. Moore, PhD JAMA May 14, 2024
Text Messages With Financial Incentives for Men With Obesity. A Randomized Clinical Trial by Pat Hoddinott, MB, BS, PhD and Catriona O’Dolan, PhD JAMA May 14, 2024
Financial Incentives for Weight Loss in Men with Obesity by JN Learning JAMA May 14, 2024
Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists by Jamy D. Ard, MD; Kristina H. Lewis, MD, and ; Justin B. Moore, PhD JAMA May 14, 2024
People With Genetic Risk of Obesity Need More Exercise to Mitigate It by Emily Harris JAMA April 19,2024
State Coverage and Reimbursement of Antiobesity Medications in Medicaid by Benjamin Y. Liu, MD and Benjamin N. Rome, MD, MPH JAMA March 18, 2024
One in 8 People Worldwide Are Obese by Samantha Anderer JAMA March 15,2024
GLP-1 Agonists for Obesity—A New Recipe for Success? by Dariush Mozaffarian, MD, DrPH JAMA February 29. 2023
Weight Loss Surgery Managed Blood Pressure for People With Obesity by Emily Harris JAMA February 14, 2024
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial by Leonard H. Epstein, PhD, Denise E. Wilfley, PhD, Colleen Kilanowski, MS, et al. JAMA June 13, 2023
Editorial: Behavioral Interventions for Treating Childhood Obesity by William J. Heerman, MD, MPH;, Ian M. Paul, MD, MSc, and Amanda E. Staiano, PhD, MPP JAMA June 13, 2023
Fat Shame—Inside and Out by MaryAnn Dakkak, MD, MPH JAMA May 8, 2023
Childhood Obesity at the Crossroads of Science and Social Justice by David S. Ludwig, MD, PhD and Jens J. Holst, MD, DMSc JAMA May 1, 2023
General Articles/Commentaries
The potential downsides of new blockbuster obesity drugs by Caitlin Owens Axios